General Information of the Compound
| Compound ID |
CP0037928
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
4-(aminomethyl)benzene-1-sulfonamide
Show/Hide
|
||||||||||||||||||
| Synonyms |
Mafenide acetate
138-39-6
4-(Aminomethyl)benzenesulfonamide
4-(aminomethyl)benzene-1-sulfonamide
4-(aminosulfonyl)benzylamine
4-Aminomethylbenzenesulfonamide
4-Homosulfanilamide
4-sulfamoylbenzylamine
Ambamide
Bensulfamide
Benzamsulfonamide
Benzenesulfonamide, 4-(aminomethyl)-
Emilene
Homonal
Homosul
Homosulfaminum
Homosulfanilamide
MAFENIDE
Mafenida [INN-Spanish]
Mafenide
Mafenidum [INN-Latin]
Malfamin
Maphenid
Maphenide
Marprontil
Mesudin
Mesudrin
Neofamid
Paramenyl
Septicid
Sulfamylon
mafenide
p-(Aminomethyl)benzenesulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C7H10N2O2S
|
||||||||||||||||||
| Molecular Weight |
186.236
|
||||||||||||||||||
| Canonical SMILES |
NCc1ccc(cc1)S(N)(=O)=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C7H10N2O2S/c8-5-6-1-3-7(4-2-6)12(9,10)11/h1-4H,5,8H2,(H2,9,10,11)
Show/Hide
|
||||||||||||||||||
| InChIKey |
TYMRLRRVMHJFTF-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
138-39-6
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound
Drug 1 ( Sulfamylon )
| Drug Name | Sulfamylon | ||
|---|---|---|---|
| Company | Mylan Inc | ||
| Indication | |||
| Target(s) | |||